ORIGINAL RESEARCH
Accepted on 30 May 2025
A Retrospective Efficacy and Safety Study of Pembrolizumab/ Cetuximab Neoadjuvant Therapy in Locally Advanced Hypopharyngeal Cancer
doi 10.3389/fimmu.2025.1574988
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Opportunities and Challenges of Head and Neck Cancer Treatment in the Era of Immune Checkpoint Inhibitors
Opportunities and Challenges of Head and Neck Cancer Treatment in the Era of Immune Checkpoint Inhibitors
7,373
Total downloads
24k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
CASE REPORT
Accepted on 26 May 2025
Long-term Immune Checkpoint Inhibitor Therapy in a Patient With Metastatic Nasopharyngeal Carcinoma: A Case Report
doi 10.3389/fimmu.2025.1585844
- 114 views
ORIGINAL RESEARCH
Published on 22 May 2025
Machine learning-driven identification of exosome- related biomarkers in head and neck squamous cell carcinoma
doi 10.3389/fimmu.2025.1590331
- 487 views
REVIEW
Accepted on 16 May 2025
Advances & Challenges in Immunotherapy in Head and Neck Cancer
doi 10.3389/fimmu.2025.1596583
- 241 views
ORIGINAL RESEARCH
Published on 08 May 2025
Oncologic outcomes following neoadjuvant immunochemotherapy in locally advanced oral squamous cell carcinoma
doi 10.3389/fimmu.2025.1571285
- 526 views
ORIGINAL RESEARCH
Published on 08 May 2025
Neoadjuvant immunochemotherapy versus neoadjuvant immunoradiotherapy in locally advanced oral squamous cell carcinoma
doi 10.3389/fimmu.2025.1563737
- 390 views
CASE REPORT
Published on 21 Mar 2025
A case of camrelizumab-induced anaphylaxis and successful rechallenge: a case report and literature review
doi 10.3389/fonc.2025.1537205
- 731 views
- 1 citation
SYSTEMATIC REVIEW
Published on 13 Feb 2025
Evaluating the efficacy and safety of immune checkpoint inhibitors in first and second-line treatments for recurrent and metastatic head and neck squamous cell carcinoma: a systematic review and network meta-analysis of RCTs with a focus on PD-L1 expression
doi 10.3389/fimmu.2025.1508885
- 2,284 views
ORIGINAL RESEARCH
Published on 16 Jan 2025
Evaluating the influence of anti-PD-1 immunotherapy combined with IMRT on thyroid dysfunction in nasopharyngeal carcinoma
doi 10.3389/fimmu.2024.1495946
- 1,079 views
CASE REPORT
Published on 24 Dec 2024
Neoadjuvant immunotherapy plus chemotherapy for squamous cell carcinoma of the paranasal sinus: a case report
doi 10.3389/fonc.2024.1462993
- 721 views
- 1 citation
CASE REPORT
Published on 24 Oct 2024
Sarcomatoid carcinoma transformation in oral undifferentiated carcinoma following sequential immune combined targeted therapy: a case report
doi 10.3389/fimmu.2024.1484915
- 542 views
REVIEW
Published on 03 Sep 2024
Immune microenvironment in papillary thyroid carcinoma: roles of immune cells and checkpoints in disease progression and therapeutic implications
doi 10.3389/fimmu.2024.1438235
- 2,311 views
- 2 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: